ZN326_HUMAN - dbPTM
ZN326_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZN326_HUMAN
UniProt AC Q5BKZ1
Protein Name DBIRD complex subunit ZNF326
Gene Name ZNF326
Organism Homo sapiens (Human).
Sequence Length 582
Subcellular Localization Nucleus matrix.
Protein Description Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions. May play a role in neuronal differentiation and is able to bind DNA and activate expression in vitro..
Protein Sequence MDFEDDYTHSACRNTYQGFNGMDRDYGPGSYGGMDRDYGHGSYGGQRSMDSYLNQSYGMDNHSGGGGGSRFGPYESYDSRSSLGGRDLYRSGYGFNEPEQSRFGGSYGGRFESSYRNSLDSFGGRNQGGSSWEAPYSRSKLRPGFMEDRGRENYSSYSSFSSPHMKPAPVGSRGRGTPAYPESTFGSRNYDAFGGPSTGRGRGRGHMGDFGSIHRPGIVVDYQNKSTNVTVAAARGIKRKMMQPFNKPSGTFIKKPKLAKPMEKISLSKSPTKTDPKNEEEEKRRIEARREKQRRRREKNSEKYGDGYRMAFTCSFCKFRTFEEKDIELHLESSSHQETLDHIQKQTKFDKVVMEFLHECMVNKFKKTSIRKQQTNNQTEVVKIIEKDVMEGVTVDDHMMKVETVHCSACSVYIPALHSSVQQHLKSPDHIKGKQAYKEQIKRESVLTATSILNNPIVKARYERFVKGENPFEIQDHSQDQQIEGDEEDEEKIDEPIEEEEDEDEEEEAEEVGEVEEVEEVEEVREGGIEGEGNIQGVGEGGEVGVVGEVEGVGEVEEVEELEEETAKEEPADFPVEQPEEN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDFEDDYT
-------CCCCHHCC
13.87-
7Phosphorylation-MDFEDDYTHSACRN
-CCCCHHCCCHHHCC
20.7627642862
8PhosphorylationMDFEDDYTHSACRNT
CCCCHHCCCHHHCCC
19.1526552605
10PhosphorylationFEDDYTHSACRNTYQ
CCHHCCCHHHCCCCC
22.6725159151
16PhosphorylationHSACRNTYQGFNGMD
CHHHCCCCCCCCCCC
15.3627642862
30PhosphorylationDRDYGPGSYGGMDRD
CCCCCCCCCCCCCCC
24.6028555341
38PhosphorylationYGGMDRDYGHGSYGG
CCCCCCCCCCCCCCC
16.3528555341
41 (in isoform 3)Acetylation-20.42-
42PhosphorylationDRDYGHGSYGGQRSM
CCCCCCCCCCCCHHH
18.2228555341
48PhosphorylationGSYGGQRSMDSYLNQ
CCCCCCHHHHHHHHH
21.0328348404
51PhosphorylationGGQRSMDSYLNQSYG
CCCHHHHHHHHHHCC
23.9128450419
52PhosphorylationGQRSMDSYLNQSYGM
CCHHHHHHHHHHCCC
12.8628450419
56PhosphorylationMDSYLNQSYGMDNHS
HHHHHHHHCCCCCCC
23.6823401153
57PhosphorylationDSYLNQSYGMDNHSG
HHHHHHHCCCCCCCC
13.5028555341
63PhosphorylationSYGMDNHSGGGGGSR
HCCCCCCCCCCCCCC
45.4421712546
64 (in isoform 3)Phosphorylation-31.08-
66 (in isoform 3)Phosphorylation-40.59-
68 (in isoform 3)Phosphorylation-20.94-
69PhosphorylationHSGGGGGSRFGPYES
CCCCCCCCCCCCCCC
27.9329978859
74PhosphorylationGGSRFGPYESYDSRS
CCCCCCCCCCCCCCC
20.2028796482
76PhosphorylationSRFGPYESYDSRSSL
CCCCCCCCCCCCCCC
28.5329083192
77PhosphorylationRFGPYESYDSRSSLG
CCCCCCCCCCCCCCC
13.1429083192
79PhosphorylationGPYESYDSRSSLGGR
CCCCCCCCCCCCCCH
26.3230576142
81PhosphorylationYESYDSRSSLGGRDL
CCCCCCCCCCCCHHH
33.5923917254
82PhosphorylationESYDSRSSLGGRDLY
CCCCCCCCCCCHHHH
29.8930576142
91PhosphorylationGGRDLYRSGYGFNEP
CCHHHHHCCCCCCCH
23.8628152594
93PhosphorylationRDLYRSGYGFNEPEQ
HHHHHCCCCCCCHHH
21.5720090780
95 (in isoform 3)Phosphorylation-7.63-
98 (in isoform 3)Phosphorylation-46.13-
101PhosphorylationGFNEPEQSRFGGSYG
CCCCHHHCCCCCCCC
28.1028555341
106PhosphorylationEQSRFGGSYGGRFES
HHCCCCCCCCCCCCH
22.4530108239
107 (in isoform 3)Phosphorylation-27.20-
107PhosphorylationQSRFGGSYGGRFESS
HCCCCCCCCCCCCHH
27.2023186163
109 (in isoform 3)Phosphorylation-23.91-
110MethylationFGGSYGGRFESSYRN
CCCCCCCCCCHHCCC
28.00115920465
113PhosphorylationSYGGRFESSYRNSLD
CCCCCCCHHCCCCCH
29.9230108239
114PhosphorylationYGGRFESSYRNSLDS
CCCCCCHHCCCCCHH
22.4030108239
115PhosphorylationGGRFESSYRNSLDSF
CCCCCHHCCCCCHHC
24.0830108239
118PhosphorylationFESSYRNSLDSFGGR
CCHHCCCCCHHCCCC
25.2625159151
121PhosphorylationSYRNSLDSFGGRNQG
HCCCCCHHCCCCCCC
30.9623911959
125MethylationSLDSFGGRNQGGSSW
CCHHCCCCCCCCCCC
32.45115386837
130PhosphorylationGGRNQGGSSWEAPYS
CCCCCCCCCCCCCCC
38.8221945579
131PhosphorylationGRNQGGSSWEAPYSR
CCCCCCCCCCCCCCH
32.0121945579
136PhosphorylationGSSWEAPYSRSKLRP
CCCCCCCCCHHHCCC
24.6221945579
137PhosphorylationSSWEAPYSRSKLRPG
CCCCCCCCHHHCCCC
29.0821945579
138MethylationSWEAPYSRSKLRPGF
CCCCCCCHHHCCCCC
31.78115386845
140SumoylationEAPYSRSKLRPGFME
CCCCCHHHCCCCCCC
47.61-
140UbiquitinationEAPYSRSKLRPGFME
CCCCCHHHCCCCCCC
47.61-
140SumoylationEAPYSRSKLRPGFME
CCCCCHHHCCCCCCC
47.6128112733
140AcetylationEAPYSRSKLRPGFME
CCCCCHHHCCCCCCC
47.6125953088
142MethylationPYSRSKLRPGFMEDR
CCCHHHCCCCCCCCC
32.79115920469
149MethylationRPGFMEDRGRENYSS
CCCCCCCCCCCCCCC
32.5354560843
154PhosphorylationEDRGRENYSSYSSFS
CCCCCCCCCCCCCCC
8.3421945579
155PhosphorylationDRGRENYSSYSSFSS
CCCCCCCCCCCCCCC
34.0921945579
156PhosphorylationRGRENYSSYSSFSSP
CCCCCCCCCCCCCCC
20.7621945579
157PhosphorylationGRENYSSYSSFSSPH
CCCCCCCCCCCCCCC
11.4621945579
158PhosphorylationRENYSSYSSFSSPHM
CCCCCCCCCCCCCCC
27.1923401153
159PhosphorylationENYSSYSSFSSPHMK
CCCCCCCCCCCCCCC
22.4021945579
161PhosphorylationYSSYSSFSSPHMKPA
CCCCCCCCCCCCCCC
44.9321945579
162PhosphorylationSSYSSFSSPHMKPAP
CCCCCCCCCCCCCCC
19.4721945579
166MethylationSFSSPHMKPAPVGSR
CCCCCCCCCCCCCCC
34.69115920457
166AcetylationSFSSPHMKPAPVGSR
CCCCCCCCCCCCCCC
34.6926051181
172PhosphorylationMKPAPVGSRGRGTPA
CCCCCCCCCCCCCCC
31.6221945579
173DimethylationKPAPVGSRGRGTPAY
CCCCCCCCCCCCCCC
32.66-
173MethylationKPAPVGSRGRGTPAY
CCCCCCCCCCCCCCC
32.6624129315
175DimethylationAPVGSRGRGTPAYPE
CCCCCCCCCCCCCCC
44.71-
175MethylationAPVGSRGRGTPAYPE
CCCCCCCCCCCCCCC
44.7154560851
177 (in isoform 3)Acetylation-11.91-
188MethylationPESTFGSRNYDAFGG
CCCCCCCCCCCCCCC
46.2154560859
190PhosphorylationSTFGSRNYDAFGGPS
CCCCCCCCCCCCCCC
13.92-
197PhosphorylationYDAFGGPSTGRGRGR
CCCCCCCCCCCCCCC
46.9322210691
198PhosphorylationDAFGGPSTGRGRGRG
CCCCCCCCCCCCCCC
33.7522210691
200DimethylationFGGPSTGRGRGRGHM
CCCCCCCCCCCCCCC
31.55-
200MethylationFGGPSTGRGRGRGHM
CCCCCCCCCCCCCCC
31.5580701879
202DimethylationGPSTGRGRGRGHMGD
CCCCCCCCCCCCCCC
30.21-
202MethylationGPSTGRGRGRGHMGD
CCCCCCCCCCCCCCC
30.2180701887
204DimethylationSTGRGRGRGHMGDFG
CCCCCCCCCCCCCCC
30.40-
204MethylationSTGRGRGRGHMGDFG
CCCCCCCCCCCCCCC
30.4080701895
212PhosphorylationGHMGDFGSIHRPGIV
CCCCCCCCCCCCEEE
18.4029691806
215MethylationGDFGSIHRPGIVVDY
CCCCCCCCCEEEEEE
29.48115920473
221 (in isoform 3)Phosphorylation-28.54-
227PhosphorylationVDYQNKSTNVTVAAA
EEECCCCCCCHHHHH
35.0028555341
235DimethylationNVTVAAARGIKRKMM
CCHHHHHHCCHHHHC
42.51-
235MethylationNVTVAAARGIKRKMM
CCHHHHHHCCHHHHC
42.5124129315
238MethylationVAAARGIKRKMMQPF
HHHHHCCHHHHCCCC
49.1124129315
238"N6,N6-dimethyllysine"VAAARGIKRKMMQPF
HHHHHCCHHHHCCCC
49.11-
239MethylationAAARGIKRKMMQPFN
HHHHCCHHHHCCCCC
30.13115386853
240AcetylationAARGIKRKMMQPFNK
HHHCCHHHHCCCCCC
33.4526051181
240SumoylationAARGIKRKMMQPFNK
HHHCCHHHHCCCCCC
33.4528112733
247AcetylationKMMQPFNKPSGTFIK
HHCCCCCCCCCCCCC
40.7219608861
247SumoylationKMMQPFNKPSGTFIK
HHCCCCCCCCCCCCC
40.7228112733
249PhosphorylationMQPFNKPSGTFIKKP
CCCCCCCCCCCCCCC
52.6623186163
251PhosphorylationPFNKPSGTFIKKPKL
CCCCCCCCCCCCCCC
26.9023917254
254SumoylationKPSGTFIKKPKLAKP
CCCCCCCCCCCCCCC
59.8528112733
260SumoylationIKKPKLAKPMEKISL
CCCCCCCCCHHHCCC
56.16-
260SumoylationIKKPKLAKPMEKISL
CCCCCCCCCHHHCCC
56.16-
260UbiquitinationIKKPKLAKPMEKISL
CCCCCCCCCHHHCCC
56.16-
264SumoylationKLAKPMEKISLSKSP
CCCCCHHHCCCCCCC
31.20-
264SumoylationKLAKPMEKISLSKSP
CCCCCHHHCCCCCCC
31.2028112733
266PhosphorylationAKPMEKISLSKSPTK
CCCHHHCCCCCCCCC
37.3423927012
266O-linked_GlycosylationAKPMEKISLSKSPTK
CCCHHHCCCCCCCCC
37.3423301498
268PhosphorylationPMEKISLSKSPTKTD
CHHHCCCCCCCCCCC
25.0530266825
268O-linked_GlycosylationPMEKISLSKSPTKTD
CHHHCCCCCCCCCCC
25.0523301498
270PhosphorylationEKISLSKSPTKTDPK
HHCCCCCCCCCCCCC
34.1329255136
272PhosphorylationISLSKSPTKTDPKNE
CCCCCCCCCCCCCCH
54.3829255136
272 (in isoform 3)Phosphorylation-54.38-
274PhosphorylationLSKSPTKTDPKNEEE
CCCCCCCCCCCCHHH
61.0722167270
277SumoylationSPTKTDPKNEEEEKR
CCCCCCCCCHHHHHH
78.70-
277SumoylationSPTKTDPKNEEEEKR
CCCCCCCCCHHHHHH
78.70-
294UbiquitinationEARREKQRRRREKNS
HHHHHHHHHHHHHHH
45.1821890473
294UbiquitinationEARREKQRRRREKNS
HHHHHHHHHHHHHHH
45.1821890473
301PhosphorylationRRRREKNSEKYGDGY
HHHHHHHHHHHCCCH
46.6720068231
303AcetylationRREKNSEKYGDGYRM
HHHHHHHHHCCCHHH
55.1225953088
304PhosphorylationREKNSEKYGDGYRMA
HHHHHHHHCCCHHHE
19.1920068231
308PhosphorylationSEKYGDGYRMAFTCS
HHHHCCCHHHEEEEE
11.2720068231
313PhosphorylationDGYRMAFTCSFCKFR
CCHHHEEEEEECCEE
9.5620068231
315PhosphorylationYRMAFTCSFCKFRTF
HHHEEEEEECCEEEE
30.5320068231
318AcetylationAFTCSFCKFRTFEEK
EEEEEECCEEEECHH
35.5525825284
325AcetylationKFRTFEEKDIELHLE
CEEEECHHCEEEEEC
57.7326051181
345UbiquitinationETLDHIQKQTKFDKV
HHHHHHHHHHHHHHH
60.37-
351AcetylationQKQTKFDKVVMEFLH
HHHHHHHHHHHHHHH
39.6026051181
364"N6,N6-dimethyllysine"LHECMVNKFKKTSIR
HHHHHHHHHHHHHHH
47.34-
364MethylationLHECMVNKFKKTSIR
HHHHHHHHHHHHHHH
47.34116265663
364AcetylationLHECMVNKFKKTSIR
HHHHHHHHHHHHHHH
47.3425953088
369PhosphorylationVNKFKKTSIRKQQTN
HHHHHHHHHHHCCCC
29.31-
372SumoylationFKKTSIRKQQTNNQT
HHHHHHHHCCCCCCC
45.12-
372SumoylationFKKTSIRKQQTNNQT
HHHHHHHHCCCCCCC
45.12-
372UbiquitinationFKKTSIRKQQTNNQT
HHHHHHHHCCCCCCC
45.12-
379PhosphorylationKQQTNNQTEVVKIIE
HCCCCCCCEEEEEEE
32.6324114839
383AcetylationNNQTEVVKIIEKDVM
CCCCEEEEEEEHHHH
43.0419608861
383UbiquitinationNNQTEVVKIIEKDVM
CCCCEEEEEEEHHHH
43.0421890473
383 (in isoform 1)Ubiquitination-43.0421890473
387AcetylationEVVKIIEKDVMEGVT
EEEEEEEHHHHCCCC
45.2625825284
394PhosphorylationKDVMEGVTVDDHMMK
HHHHCCCCCCCCEEE
29.1320860994
401SumoylationTVDDHMMKVETVHCS
CCCCCEEEEEEEECC
29.3728112733
413PhosphorylationHCSACSVYIPALHSS
ECCHHHHHHHHHHHH
5.7228122231
419PhosphorylationVYIPALHSSVQQHLK
HHHHHHHHHHHHHHC
32.8128122231
420PhosphorylationYIPALHSSVQQHLKS
HHHHHHHHHHHHHCC
17.1328122231
426UbiquitinationSSVQQHLKSPDHIKG
HHHHHHHCCCCHHCC
58.79-
427PhosphorylationSVQQHLKSPDHIKGK
HHHHHHCCCCHHCCH
41.7530576142
438SumoylationIKGKQAYKEQIKRES
HCCHHHHHHHHHHHH
46.27-
438SumoylationIKGKQAYKEQIKRES
HCCHHHHHHHHHHHH
46.27-
442SumoylationQAYKEQIKRESVLTA
HHHHHHHHHHHCHHH
50.21-
445PhosphorylationKEQIKRESVLTATSI
HHHHHHHHCHHHHHH
26.8527067055
450PhosphorylationRESVLTATSILNNPI
HHHCHHHHHHHCCHH
15.86-
451PhosphorylationESVLTATSILNNPIV
HHCHHHHHHHCCHHH
23.71-
459SumoylationILNNPIVKARYERFV
HHCCHHHHHHHHHHH
28.06-
459SumoylationILNNPIVKARYERFV
HHCCHHHHHHHHHHH
28.0628112733
459UbiquitinationILNNPIVKARYERFV
HHCCHHHHHHHHHHH
28.06-
467SumoylationARYERFVKGENPFEI
HHHHHHHCCCCCCCC
58.77-
467SumoylationARYERFVKGENPFEI
HHHHHHHCCCCCCCC
58.7728112733
467UbiquitinationARYERFVKGENPFEI
HHHHHHHCCCCCCCC
58.77-
478PhosphorylationPFEIQDHSQDQQIEG
CCCCCCCCCCCCCCC
43.6825159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ZN326_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZN326_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZN326_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRNP1_HUMANBRINP1physical
22446626
ROA1_HUMANHNRNPA1physical
22446626
RPB1_HUMANPOLR2Aphysical
22446626

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZN326_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-247, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137 AND SER-270, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270 AND THR-274, ANDMASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-274, AND MASSSPECTROMETRY.

TOP